Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 4464321)

Published in Mol Med Rep on April 17, 2015

Authors

Hongchao Yan1, Jianye Tong1, Xiaoman Lin1, Qiuyu Han1, Hongxiang Huang1

Author Affiliations

1: Department of Obstetrics and Gynecology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221002, P.R. China.

Articles cited by this

Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57

Cell cycle control and cancer. Science (1994) 10.90

Stem cells: units of development, units of regeneration, and units in evolution. Cell (2000) 7.36

Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res (2008) 6.38

The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells (2003) 4.11

WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res (2000) 4.07

Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene (1995) 3.96

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res (2005) 3.79

WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79

Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci U S A (2007) 2.37

The opposing roles of Wnt-5a in cancer. Br J Cancer (2009) 2.07

Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci U S A (2004) 1.91

Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A. J Biol Chem (2008) 1.72

Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem (2009) 1.41

WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome. BMC Cancer (2005) 1.22

Metals and apoptosis: recent developments. J Trace Elem Med Biol (2008) 1.21

17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo. Oncogene (2005) 1.18

The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies. Recent Pat CNS Drug Discov (2010) 1.16

Tumor stem cells. Pathol Oncol Res (2004) 1.11

Ovarian cancer: emerging concept on cancer stem cells. J Ovarian Res (2008) 1.08

Ovarian cancer: diagnosis and treatment. Dtsch Arztebl Int (2011) 1.05

Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung. Pathol Int (2002) 1.00

WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear. Int J Oncol (2005) 0.99

Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3. Ultrastruct Pathol (2009) 0.99

Ovarian epithelial cancer stem cells. ScientificWorldJournal (2011) 0.95

Ovarian stem cells--potential roles in infertility treatment and fertility preservation. Maturitas (2013) 0.92

Ovarian cancer stem cells. Neoplasma (2012) 0.92

Epithelial ovarian cancer: An overview. World J Transl Med (2014) 0.91

Cancer stem cells and epithelial ovarian cancer. J Oncol (2011) 0.89

CDKs give Cdc6 a license to drive into S phase. Cell (2005) 0.85

The cooperative role of p27 with cyclin E in the prognosis of advanced gastric carcinoma. Cancer (2000) 0.84

Discovery of prognostic factors for diagnosis and treatment of epithelial-derived ovarian cancer from laying hens. J Cancer Prev (2013) 0.83

Ovarian cancer stem cells enrichment. Methods Mol Biol (2013) 0.83

Amplified CDK2 and cdc2 activities in primary colorectal carcinoma. Cancer (1999) 0.82